During the coronavirus pandemic in February, Beijing-based medtech BioMind managed to train its AI-diagnostic platform to identify Covid-19 symptoms using CT scans of a patient’s lungs. Within a month, the service was made available free to all Covid-designated hospitals in China.“Many AI companies working on medical images are deploying AI specific to one disease or one body part. If we want AI to really help doctors, we couldn’t limit it like that,” said Liang Weimin, chairman of BioMind. “In the future, we want BioMind to serve in radiology department, as well as other clinical departments...
© BioMind
